AI assistant
Traws Pharma, Inc. — Director's Dealing 2015
May 21, 2015
35199_dirs_2015-05-21_245df740-7f6d-411e-b055-fbb46b2f5c60.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 3 — Initial Statement of Beneficial Ownership
Issuer: Onconova Therapeutics, Inc. (ONTX)
CIK: 0001130598
Period of Report: 2015-04-27
Reporting Person: Maniar Manoj (SVP - Product Development)
Holdings (Derivative)
| Security | Exercise Price | Expiration | Underlying | Shares | Ownership |
|---|---|---|---|---|---|
| Stock Option (right to buy) | $6.00 | 2017-08-01 | Common Stock (11252) | Direct | |
| Stock Option (right to buy) | $5.76 | 2020-03-17 | Common Stock (37509) | Direct | |
| Stock Option (right to buy) | $5.76 | 2020-03-17 | Common Stock (18754) | Direct | |
| Stock Option (right to buy) | $6.13 | 2020-12-10 | Common Stock (7501) | Direct | |
| Stock Option (right to buy) | $6.13 | 2020-12-10 | Common Stock (18754) | Direct | |
| Stock Option (right to buy) | $6.13 | 2021-12-05 | Common Stock (3780) | Direct | |
| Stock Option (right to buy) | $13.28 | 2022-12-18 | Common Stock (30007) | Direct | |
| Stock Option (right to buy) | $15.00 | 2023-07-25 | Common Stock (5000) | Direct | |
| Stock Option (right to buy) | $13.48 | 2023-12-20 | Common Stock (40000) | Direct | |
| Stock Option (right to buy) | $3.98 | 2024-12-18 | Common Stock (60000) | Direct | |
| Stock Option (right to buy) | $2.32 | 2025-04-16 | Common Stock (40000) | Direct |
Footnotes
F1: This option, representing a right to buy, vests over 4 years, with 25% vesting on December 18,2013 and 75% vesting in 36 equal monthly installments thereafter, subject to continued service to the issuer.
F2: This option, representing a right to buy, vests over 4 years, with 25% vesting on July 25,2014 and 75% vesting in 36 equal monthly installments thereafter, subject to continued service to the issuer.
F3: This option, representing a right to buy, vests in 48 equal monthly installments over 4 years. The first shares vest one month after the date of grant, which was December 20, 2013.
F4: This option, representing a right to buy, vests in 48 equal monthly installments over 4 years. The first shares vest one month after the date of grant, which was December 18, 2014.
F5: This option, representing a right to buy, vests in 48 equal monthly installments over 4 years. The first shares vest one month after the date of grant, which was April 16, 2015.